Evidence map›Paper›PMID 32355837›Full record

ReviewAnnals of translational medicine2020

Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV).

Kamal Kant Sahu, Ajay Kumar Mishra, Amos Lal

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04568525 (Microwave Radiation for Early Diagnostics of Pneumonia in Patients With COVID-19), which is not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04568525 nacompletednot on this map

Microwave Radiation for Early Diagnostics of Pneumonia in Patients With COVID-19

TypeinterventionalSponsorKyrgyz State Medical AcademyRan2020 to 2020Enrolled195ConditionsCovid19ArmsPassive Microwave Radiometry
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 97 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. COVID-19 Preventive Practices among Bus Station Workers in Ethiopia.The American journal of tropical medicine and hygiene · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The Pathogenesis and Treatment of COVID-19: A System Review.Biomedical and environmental sciences : BES · 2021
    Article
  15. Article
  16. Article
  17. Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic.Advances in experimental medicine and biology · 2021
    Article
  18. Challenges of Cellular Therapy During the COVID-19 Pandemic.Advances in experimental medicine and biology · 2021
    Article
  19. COVID-19 and stroke, a case series and review of literature.Brain, behavior, & immunity - health · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kamal Kant SahuDepartment of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Ajay Kumar MishraDepartment of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
Amos LalDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Saint Vincent Hospital · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a new coronavirus disease (COVID-19) has emerged as a respiratory infection with significant concern for global public health hazards. With an initial suspicion of the animal to the human transmission for earlier cases, now the paradigm has shifted towards human to human transmission via droplets, contacts and/or through fomites. with each passing day, more and more confirmed cases are being reported worldwide which has alarmed the global authorities including World Health Organization (WHO), Centers for Disease Control and Prevention (CDC) and the National Health Commission of the People's Republic of China to take immediate action in order to reduce the transmission and subsequent mortalities associated with COVID-19 to as minimum as possible. Unfortunately, like the previous Coronavirus outbreaks, there is no definite antiviral therapy for the treatment of confirmed cases and hence preventing ourselves from contracting 2019-nCoV is the best way to prevent it from becoming pandemic. Herein, we aim to discuss the latest updates on the origin, genomic characteristics, diagnosis, treatment options and current efforts being made by international health organizations with regards to the 2019-nCoV outbreak.

Indexed as

coronavirusquarantine periodRespiratory diseaseviral infectionWorld Health Organization

Identifiers

PMID32355837
PMCPMC7186600
OpenAlexW3007394480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.